Company Information

Headquarters
United States
Founded in
2001
Employees
51 - 200( View All )
Speciality
cancer researchdrug developmentbioconjugationoncology
Overview
Mersana is rewriting the rules for immunoconjugate therapies by leveraging our Fleximer platform to create precisely targeted and highly tailored drugs that radically improve patients’ lives. Our Fleximer platform allows us to custom design an ADC with specific properties to overcome limitations of current ADC approaches and increase the drug’s chances of effectively attacking a particular cancer. We engineer immunoconjugates to deliver industry-leading payloads of an array of anti-tumor agents directly to cancerous cells, controlling when, where and how those agents are released. Because we can safely deliver higher quantities of therapeutic payloads directly to a tumor, Mersana’s ADC therapies have the potential to more effectively treat broader populations of cancer patients while significantly reducing the side effects associated with many of today’s cancer treatments.
search

Sign Up to View Mersana Therapeutics’s Top Employees

Instant access. Cancel anytime

Similar Companies

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

Instant access. Cancel anytime

Get Contact Info for All Employees

Employees:

static-employee
Charlene Cormier

Senior Manager Talent Acquisition

static-employee
Mohan Bala

SVP, Strategic Product Planning & Program Leadership

static-employee
Scott David Collins

Associate Director, Pharmacology & Toxicology


static-employee
June Sprecher

Director, Safety and Pharmacovigilance

static-employee
Orhan Karsligil

Executive Director, IT AND Facilities